Loading asset research
Valion Bio Inc. Common Stock
VBIONasdaq · USD · StocksQuote as of · Exchange session not verified$2.26
+2.73%
Today
VBIO
Loading 1D prices…
Market cap
$2M
Volume
161K
52w high
$4.7052w low
$0.112Company profile
Valion Bio Inc. Common Stock
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Antonio, TX, United States
Employees
52
Fiscal year end
1231
CIK
1787740
Session & valuation
Open$2.19
Previous close$2.20
Day high$2.39
Day low$2.17
30-day avg. volume13.6M
Outstanding shares22.2M
Diluted EPS-$196.00
Latest annual period
P/E (trailing)-0.01
P/E (forward)—
Price / book2.21
Beta1.79
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SHPHShuttle Pharmaceuticals Holdings Inc. Common Stock | $2.1M | $0.00 | — | -$7.16 | 0.00% | Unrated |
| PPCBPropanc Biopharma Inc. Common Stock | $2.1M | $0.00 | — | -$23.82 | -2.34% | Unrated |
| OGENOragenics Inc. Common Stock | $2.2M | $0.00 | — | -$4.56 | -4.40% | Unrated |
| RNAZTransCode Therapeutics Inc. Common Stock | $1.8M | $0.00 | — | -$52.59 | 0.00% | Unrated |
| DCOYDecoy Therapeutics Inc. Common Stock | $1.7M | $0.00 | — | -$129.10 | -2.20% | Buy |